Blocking of EGF-mediated EMT, cell migration and invasion, and metastasis formation by Cetuximab treatment was also demonstrated in OSCC, HNSCC, and esophageal squamous cell carcinomas [88,93,94,95]. This evidence concerns the gene EGF and head and neck squamous cell carcinoma.